A detailed history of West Paces Advisors Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, West Paces Advisors Inc. holds 19,489 shares of MRK stock, worth $2.18 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
19,489
Previous 19,557 0.35%
Holding current value
$2.18 Million
Previous $2.58 Billion 6.5%
% of portfolio
0.63%
Previous 0.68%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$123.8 - $132.96 $8,418 - $9,041
-68 Reduced 0.35%
19,489 $2.41 Billion
Q1 2024

Apr 15, 2024

SELL
$113.24 - $131.95 $85,382 - $99,490
-754 Reduced 3.71%
19,557 $2.58 Billion
Q4 2023

Jan 30, 2024

SELL
$100.18 - $109.02 $9,216 - $10,029
-92 Reduced 0.45%
20,311 $2.21 Billion
Q3 2023

Dec 18, 2023

SELL
$102.95 - $114.33 $135,688 - $150,686
-1,318 Reduced 6.07%
20,403 $2.1 Billion
Q2 2023

Dec 18, 2023

SELL
$108.61 - $118.38 $11,512 - $12,548
-106 Reduced 0.49%
21,721 $2.51 Billion
Q1 2023

Dec 18, 2023

BUY
$102.94 - $114.86 $33,043 - $36,870
321 Added 1.49%
21,827 $2.32 Billion
Q4 2022

Dec 18, 2023

BUY
$87.44 - $112.11 $1.88 Million - $2.41 Million
21,506 New
21,506 $2.39 Billion
Q3 2022

Dec 18, 2023

BUY
$84.53 - $94.96 $1,183 - $1,329
14 Added 0.07%
21,437 $1.85 Billion
Q2 2022

Dec 18, 2023

BUY
$83.49 - $94.64 $42,830 - $48,550
513 Added 2.45%
21,423 $1.95 Billion
Q1 2022

Dec 18, 2023

BUY
$73.51 - $82.4 $37,269 - $41,776
507 Added 2.48%
20,910 $1.72 Billion
Q4 2021

Dec 19, 2023

SELL
$72.28 - $90.54 $35,200 - $44,092
-487 Reduced 2.44%
19,456 $1.49 Billion
Q3 2021

Dec 19, 2023

BUY
$71.68 - $78.83 $38,993 - $42,883
544 Added 2.8%
19,943 $1.5 Billion
Q2 2021

Dec 19, 2023

BUY
$70.31 - $77.77 $703 - $777
10 Added 0.05%
19,399 $1.51 Billion
Q1 2021

Dec 19, 2023

BUY
$68.86 - $81.11 $80,290 - $94,574
1,166 Added 6.4%
19,389 $1.49 Billion
Q4 2020

Dec 19, 2023

BUY
$71.77 - $79.65 $125,884 - $139,706
1,754 Added 10.65%
18,223 $1.49 Billion
Q3 2020

Dec 19, 2023

BUY
$73.18 - $82.95 $226,931 - $257,227
3,101 Added 23.2%
16,469 $1.37 Billion
Q2 2020

Dec 19, 2023

SELL
$70.42 - $80.13 $495,404 - $563,714
-7,035 Reduced 34.48%
13,368 $1.03 Billion
Q1 2020

Dec 20, 2023

BUY
$63.36 - $87.82 $251,032 - $347,942
3,962 Added 112.3%
7,490 $576 Million
Q4 2019

Dec 21, 2023

BUY
$77.58 - $87.54 $53,607 - $60,490
691 Added 19.59%
4,219 $384 Million
Q4 2018

Dec 21, 2023

SELL
$65.24 - $75.71 $3,457 - $4,012
-53 Reduced 1.48%
3,528 $270 Million
Q3 2018

Dec 20, 2023

SELL
$57.69 - $67.84 $973,518 - $1.14 Million
-16,875 Reduced 82.71%
3,528 $250 Million
Q2 2018

Dec 21, 2023

BUY
$50.83 - $59.72 $8,691 - $10,212
171 Added 5.01%
3,581 $217 Million
Q1 2018

Dec 21, 2023

SELL
$50.96 - $59.23 $214,490 - $249,299
-4,209 Reduced 55.24%
3,410 $186 Million
Q4 2017

Dec 21, 2023

SELL
$51.62 - $61.64 $374,245 - $446,890
-7,250 Reduced 48.76%
7,619 $429 Million
Q3 2017

Dec 21, 2023

SELL
$58.67 - $63.13 $12,438 - $13,383
-212 Reduced 1.41%
14,869 $952 Million
Q2 2017

Dec 21, 2023

SELL
N/A
-25 Reduced 0.17%
15,081 $967 Million
Q1 2017

Dec 21, 2023

BUY
N/A
569 Added 3.91%
15,106 $960 Million
Q4 2016

Dec 21, 2023

SELL
N/A
-5,866
14,537 $856 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $284B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track West Paces Advisors Inc. Portfolio

Follow West Paces Advisors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West Paces Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on West Paces Advisors Inc. with notifications on news.